Testing oral amino acid supplements for advanced liver disease
Part of Digestive system clinical trials.
This trial tests if taking branched-chain amino acids by mouth can help people with cirrhosis and ascites (fluid in the belly). It aims to improve nutrition and reduce complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cirrhosis (scarring of the liver) from any cause
- You are between 18 and 85 years old
- You have ascites (fluid buildup in your abdomen that a doctor can find)
- Your blood albumin level is below 3 g/dL
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a personalized long-term albumin (a blood protein medicine) can help people with advanced liver scarring who have fluid in the belly (ascites). It compares the personalized albumin approach to standard care to see if it improves outcomes over time.
This study tests whether taking a daily drink of branched-chain amino acids (a type of protein) can help people with liver cirrhosis who have lost muscle strength and mass. It may help improve muscle size and function.
This trial tests whether a special amino-acid supplement can help reverse muscle loss in people with cirrhosis (scarring of the liver). It may help maintain or improve muscle strength and overall function, but eligibility depends on your liver status and overall health.
This trial tests whether a special mix of amino acids (building blocks for muscle) can help reverse muscle loss in people with cirrhosis. It aims to improve muscle health while keeping you safe from known complications of liver disease.
This trial tests whether adding branched-chain amino acids (BCAA) to the standard TIPS procedure helps people with cirrhosis and muscle wasting. It aims to see if BCAA can improve outcomes after TIPS.
This study focuses on assessing nutrition in adults living with liver cirrhosis. The goal is to understand nutritional needs and how assessment may support care.
Hear when a new Decompensated Cirrhosis and Ascites trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.